Study Evaluating Food Effect and QTc in Patients With Advanced Malignancies
NCT05391022
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
35
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Malignancies
Solid Tumor
Hematological Malignancy
Interventions
DRUG:
Pelabresib
Sponsor
Constellation Pharmaceuticals